Welcome to InfiCure Bio

InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.

Based on a panel of in vivo models for these conditions including a proprietary model, the NIF mouse, for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.

Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.

Contact us

News

Visit InfiCure Poster at EASL in June 22-26!

InfiCure Bio will attend the yearly EASL meeting with a poster, please take the opportunity to check out poster #FRI-154 "NKT cells promote both type 1 and type 2 inflammatory responses in the non-obese diabetic [...]

InfiCure Bio at Umeå Life Science Job Fair!

Today on May 3rd, Umeå Biotech Incubator (UBI)  organized the first Umeå Life Science Job Fair. We at InfiCure Bio were happy to get the opportunity to present our business to life science students and [...]